Skip to content

Lipum AB Sustainability Reports

Lipum AB is a clinical-stage biopharmaceutical company focused on discovering and developing novel biological treatments for chronic inflammatory diseases.

Sector: Manufacturing

Country: Sweden

Exchange: Nasdaq Stockholm

LEI: 549300V7JL0004BHBD93

FIGI: BBG00DQ5HC60

1 reports from 2020 to 2020